Trial Profile
A multicentre, prospective, pilot study of Sofosbuvir, Ledipasvir with and without Ribavirin in the treatment of chronic hepatitis C in patients with moderate to severe inflammatory bowel disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 May 2016
Price :
$35
*
At a glance
- Drugs Ledipasvir (Primary) ; Sofosbuvir (Primary) ; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms Solataire C
- 17 Apr 2016 Efficacy results presented at The International Liver Congress 2016.
- 23 Feb 2016 New trial record